Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Funding Level Creates Problems Beyond Staff Shortages – OND Head

This article was originally published in The Tan Sheet

Executive Summary

FDA's funding level not only limits its staffing resources, but also prevents it from starting necessary information technology upgrades and from supporting research crucial to improving the efficacy and safety of OTC and other drugs, says Office of New Drugs Direct John Jenkins, MD
Advertisement

Related Content

Sweeping Changes At CDER Recommended In IoM Drug Safety Report
Sweeping Changes At CDER Recommended In IoM Drug Safety Report

Topics

Advertisement
UsernamePublicRestriction

Register

PS099868

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel